The negative correlation between CDA and MAPT transcript levels was significant in cancers of several tissues, including breast cancer (Fig. 5c), papillary, and clear cell kidney carcinomas (Fig. 5d, e), prostate adenocarcinoma (Fig. 5f), and pheochromocytoma and paraganglioma (Fig. 5g). The gene discussed is MAPT; the disease is pheochromocytoma.